2,424
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Improvements in concentration, working memory and sustained attention following consumption of a natural citicoline–caffeine beverage

, , &
Pages 1003-1007 | Received 08 Apr 2014, Accepted 25 Jun 2014, Published online: 21 Jul 2014

References

  • Arnett JA, Labovitz SS. 1995. Effect of physical layout in performance of the Trail Making Test. Psychol Assess 7:220–221
  • Babb SM, Wald LL, Cohen BM, Villafuerte RA, Gruber SA, Yurgelun-Todd DA, Renshaw PF. 2002. Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study. Psychopharmacol (Berl) 161:248–254
  • Barker RG. 1931. The stepping-stone maze: a directly visible space-problem apparatus. J Gen Psychol 5:280–285
  • Bruce SE. 2012. Improvements in quantitative EEG following consumption of a natural citicoline-enhanced beverage. Int J Food Sci Nutr 63:421–425
  • Clark CR, Orr RS, Wright EK, Weber DL. 1998. Working memory updating to visual verbal stimuli: a high resolution ERP study. Brain Topogr Today. Tokyo: Elsevier Science. p 173–178
  • Conant R, Schauss AG. 2004. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature. Altern Med Rev 9:17–31
  • Cotroneo AM, Castagna A, Putignano S, Lacava R, Fantò F, Monteleone F, Rocca F, et al. 2013. Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study. Clin Interv Aging 8:131–137
  • Crowe SF, Barclay L, Brennan S, Farkas L, Gould E, Katchmarsky S, Vayda S. 1999. The cognitive determinants of performance on the Austin Maze. J Int Neuropsychol Soc 5:1–9
  • Einöther SJ, Giesbrecht T. 2013. Caffeine as an attention enhancer: reviewing existing assumptions. Psychopharmacol (Berl) 225:251–274
  • Gatti G, Barzaghi N, Acuto G, Abbiati G, Fossati T, Perucca E. 1992. A comparative study of free plasma choline levels following intramuscular administration of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteers. Int J Clin Pharm Ther Toxicol 30:331–335
  • Haller S, Rodriguez C, Moser D, Toma S, Hofmeister J, Sinanaj I, Van De Ville D, et al. 2013. Acute caffeine administration impact on working memory-related brain activation and functional connectivity in the elderly: a BOLD and perfusion MRI study. Neuroscience 250:364–371
  • Hermens DF, Williams LM, Clarke S, Kohn M, Cooper N, Gordon E. 2005. Responses to methylphenidate in adolescent AD/HD: Evidence from concurrently recorded autonomic (EDA) and central (EEG and ERP) measures. Int J Psychophysiol 58:21–33
  • Hocking J, Thomas HJ, Dzafic I, Williams RJ, Reutens DC, Spooner DM. 2013. Disentangling the cognitive components supporting austin maze performance in left versus right temporal lobe epilepsy. Epilepsy Behav 29:485–491
  • Huang-Pollock CL, Karalunas SL, Tam H, Moore AN. 2012. Evaluating vigilance deficits in ADHD: a meta-analysis of CPT performance. J Abnorm Psychol 121:360–371
  • Keage HA, Clark CR, Hermens DF, Williams LM, Kohn MR, Clarke S, Lamb C, et al. 2008. ERP indices of working memory updating in AD/HD: differential aspects of development, subtype, and medication. J Clin Neurophysiol 25:32–41
  • Koppelstaetter F, Poeppel TD, Siedentopf CM, Ischebeck A, Verius M, Haala I, Mottaghy FM, et al. 2008. Does caffeine modulate verbal working memory processes? An fMRI study. Neuroimage 39:492–499
  • Lezak MD, Howieson DB, Bigler ED, Tranel D. 2012. Neuropsychological assessment. 5th ed. New York: Oxford
  • Mangina CA, Beuzeron-Mangina J, Grizenko N. 2000. Event-related brain potentials, bilateral electrodermal activity and Mangina-Test performance in learning disabled ADHD pre-adolescents with severe behavioral disorders as compared to age-matched normal controls. Int J Psychophysiol 37:71–85
  • Milner B. 1965. Visually-guided maze learning in man: effects of bilateral hippocampal, bilateral frontal, and unilateral cerebral lesions. Neuropsychology 3:317–338
  • Perry RJ, Hodges JR. 1999. Attention and executive deficits in Alzheimer's disease: a critical review. Brain 122:383–404
  • Riccio CA, Reynolds CR, Lowe P, Moore JJ. 2002. The continuous performance test: a window on the neural substrates for attention? Arch Clin Neuropsychol 17:235–272
  • Riccio CA, Waldrop JJM, Reynolds CR, Lowe P. 2001. Effects of stimulants on the continuous performance test (CPT): implications for CPT use and interpretation. J Neuropsychiatry Clin Neurosci 13:326–335
  • Rossi M, Zanardi M. 1993. An open study on the clinical efficacy of citicoline in patients with chronic cerebral vasculopathy. Clin Ter 142:141–144
  • Secades JJ. 2011. Citicoline: pharmacological and clinical review, 2010 update. Rev Neurol 14:S1–S62
  • Secades JJ, Lorenzo JL. 2006. Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol 28:1–56
  • Silveri MM, Dikan J, Ross AJ, Jensen JE, Kamiya T, Kawada Y, Renshaw PF, et al. 2008. Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopy. NMR Biomed 21:1066–1075
  • Weafer J, Baggott MJ, de Wit H. 2013. Test–retest reliability of behavioral measures of impulsive choice, impulsive action, and inattention. Exp Clin Psychopharm 21:475–481
  • Wechsler D. 1981. Wechsler adult intelligence scale – revised manual. New York: Psychological Corporation
  • Williams LM, Hermens DF, Thein T, Clark CR, Cooper NJ, Clarke SD, Lamb C, et al. 2010. Using brain-based cognitive measures to support clinical decisions in ADHD. Pediatr Neurol 42:118–126
  • Zhang LN, Sun YJ, Pan S, Li JX, Qu YE, Li Y, Wang YL, Gao ZB. 2013. Na+-K+-ATPase, a potent neuroprotective modulator against Alzheimer disease. Fundam Clin Pharmacol 27:96–103

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.